Temat: "Hepatitis C" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: An amino acid substitution in HCV core antigen limits its use as a reliable measure of HCV infection compared with HCV RNA.
Autorzy:: Hansoongnern P; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Pratedrat P; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Nilyanimit P; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Wasitthankasem R; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; National Biobank of Thailand, National Science and Technology Development Agency, Pathum Thani, Thailand.
Posuwan N; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Wanlapakorn N; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Kodchakorn K; Thailand Excellence Center for Tissue Engineering and Stem Cells, Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Kongtawelert P; Thailand Excellence Center for Tissue Engineering and Stem Cells, Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Pimsing N; Non-Communicable Disease Control Group, Phetchabun Provincial Health Office, Phetchabun, Thailand.
Poovorawan Y; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; Fellow of the Royal Society of Thailand (FRS[T]), the Royal Society of Thailand, Sanam Sueapa, Bangkok, Thailand.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Jun 29; Vol. 18 (6), pp. e0287694. Date of Electronic Publication: 2023 Jun 29 (Print Publication: 2023).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hepatitis C*/diagnosis
Liver Neoplasms*
Humans ; Hepacivirus/genetics ; Amino Acid Substitution ; Hepatitis C Antigens/genetics ; Hepatitis C Antibodies ; RNA

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Longitudinal assessment of HCV core antigen kinetics to monitor therapeutic response in the age of DAAs.
Autorzy:: Ponnuvel S; Department of Clinical Virology, Christian Medical College, Vellore, India.
Prakash A; Department of Clinical Virology, Christian Medical College, Vellore, India.
Steve RJ; Department of Clinical Virology, Christian Medical College, Vellore, India.
Doss GP; Department of Integrative Biology, Vellore Institute of Technology, Vellore, India.
Goel A; Department of Hepatology, Christian Medical College, Vellore, India.
Zachariah UG; Department of Hepatology, Christian Medical College, Vellore, India.
Eapen CE; Department of Hepatology, Christian Medical College, Vellore, India.
Rebekah G; Department of Biostatistics, Christian Medical College, Vellore, India.
Kannangai R; Department of Clinical Virology, Christian Medical College, Vellore, India.
Fletcher GJ; Department of Clinical Virology, Christian Medical College, Vellore, India.
Abraham P; Department of Clinical Virology, Christian Medical College, Vellore, India.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Feb 17; Vol. 18 (2), pp. e0282013. Date of Electronic Publication: 2023 Feb 17 (Print Publication: 2023).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antiviral Agents*/therapeutic use
Hepatitis C, Chronic*/drug therapy
Humans ; Longitudinal Studies ; RNA, Viral/genetics ; Hepacivirus/genetics ; Hepatitis C Antigens ; Recurrence ; Genotype

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Qualitative hepatitis C virus RNA assay identifies active infection with sufficient viral load for treatment among Phetchabun residents in Thailand.
Autorzy:: Pratedrat P; Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Nilyanimit P; Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Wasitthankasem R; National Biobank of Thailand, National Science and Technology Development Agency, Pathum Thani, Thailand.
Posuwan N; Chulabhorn International College of Medicine, Thammasat University, Rangsit Campus, Pathum Thani, Thailand.
Auphimai C; Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Hansoongnern P; Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Pimsing N; Non-Communicable Disease Control Group, Phetchabun Provincial Health Office, Phetchabun, Thailand.
Ngamnimit S; Non-Communicable Disease Control Group, Phetchabun Provincial Health Office, Phetchabun, Thailand.
Thongmai C; Phetchabun Provincial Public Health Office, Phetchabun, Thailand.
Phaengkha W; Namnao Hospital, Phetchabun, Thailand.
Wanlapakorn N; Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Vongpunsawad S; Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Poovorawan Y; Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; FRS(T), The Royal Society of Thailand, Bangkok, Thailand.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Jan 19; Vol. 18 (1), pp. e0268728. Date of Electronic Publication: 2023 Jan 19 (Print Publication: 2023).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hepatitis C*/diagnosis
Hepatitis C*/epidemiology
Hepatitis A*
Humans ; Adult ; Middle Aged ; Aged ; Hepacivirus/genetics ; Viral Load/methods ; Thailand/epidemiology ; RNA, Viral/genetics ; Hepatitis C Antibodies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Prevalence of hepatitis B and C virus infections in Lao People's Democratic Republic: The first national population-based cross-sectional survey.
Autorzy:: Miyano S; Bureau of International Health Cooperation and WHO Collaborating Center for Health Systems Development, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan.
Pathammavong C; National Immunization Program, Mother and Child Health Center, Ministry of Health, Lao People's Democratic Republic (Lao PDR), Vientiane Capital, Lao PDR.
Ichimura Y; Bureau of International Health Cooperation and WHO Collaborating Center for Health Systems Development, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan.
Sugiyama M; Genome Medical Science Project, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikwa, Chiba, Japan.
Phounphenghack K; National Immunization Program, Mother and Child Health Center, Ministry of Health, Lao People's Democratic Republic (Lao PDR), Vientiane Capital, Lao PDR.
Tengbriacheu C; Mother and Child Health Center, Ministry of Health, Vientiane Capital, Lao PDR.
Khamphaphongphane B; National Center Laboratory and Epidemiology, Ministry of Health, Vientiane Capital, Lao PDR.
Nouanthong P; Institute Pasteur du Laos, National Immunization Technical Advisory Group, Ministry of Health, Vientiane Capital, Lao PDR.
Franzel L; Vaccine-Preventable Diseases and Immunization Team, WHO Lao PDR, Vientiane Capital, Lao PDR.
Yang TU; Vaccine-Preventable Diseases and Immunization Team, WHO Lao PDR, Vientiane Capital, Lao PDR.
Raaijimakers H; Health and Nutrition Section, UNICEF, Vientiane Capital, Lao PDR.
Ota T; Bureau of International Health Cooperation and WHO Collaborating Center for Health Systems Development, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan.
Funato M; Bureau of International Health Cooperation and WHO Collaborating Center for Health Systems Development, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan.
Komada K; Bureau of International Health Cooperation and WHO Collaborating Center for Health Systems Development, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan.
Hachiya M; Bureau of International Health Cooperation and WHO Collaborating Center for Health Systems Development, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 Dec 30; Vol. 17 (12), pp. e0278933. Date of Electronic Publication: 2022 Dec 30 (Print Publication: 2022).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hepatitis B, Chronic*/epidemiology
Hepatitis B*
Hepatitis C*/epidemiology
Humans ; Male ; Young Adult ; Adult ; Cross-Sectional Studies ; Hepatitis B Surface Antigens ; Laos/epidemiology ; Prevalence ; Seroepidemiologic Studies ; Hepatitis C Antibodies ; Hepatitis B virus

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Patient-derived monoclonal antibody neutralizes HCV infection in vitro and vivo without generating escape mutants.
Autorzy:: Yokokawa H; Pharmaceutical Research Laboratory, Toray Industries, Inc., Kanagawa, Japan.; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
Shinohara M; Medical & Biological Laboratories Co., Ltd., Tokyo, Japan.
Teraoka Y; Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.
Imamura M; Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.
Nakamura N; Pharmaceutical Research Laboratory, Toray Industries, Inc., Kanagawa, Japan.
Watanabe N; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
Date T; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
Aizaki H; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
Iwamura T; Pharmaceutical Research Laboratory, Toray Industries, Inc., Kanagawa, Japan.
Narumi H; Pharmaceutical Research Laboratory, Toray Industries, Inc., Kanagawa, Japan.
Chayama K; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.; Collaborative Research Laboratory of Medical Innovation, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Wakita T; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 Sep 22; Vol. 17 (9), pp. e0274283. Date of Electronic Publication: 2022 Sep 22 (Print Publication: 2022).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hepatitis C*
Hepatitis C, Chronic*
Animals ; Antibodies, Monoclonal ; Antibodies, Neutralizing ; Antiviral Agents/metabolism ; Epitopes ; Hepacivirus ; Hepatitis C Antibodies ; Humans ; Mice ; Peptide Library ; Viral Envelope Proteins

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Hepatitis B virus-related hepatocellular carcinoma has superior overall survival compared with other etiologies.
Autorzy:: Yen YH; Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Kee KM; Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Hu TH; Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Tsai MC; Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Kuo YH; Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Li WF; Liver Transplantation Center and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Liu YW; Liver Transplantation Center and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Wang CC; Liver Transplantation Center and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Lin CY; Biostatistics Center of Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 15; Vol. 19 (3), pp. e0290523. Date of Electronic Publication: 2024 Mar 15 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/etiology
Carcinoma, Hepatocellular*/therapy
Liver Neoplasms*/pathology
Hepatitis C*/complications
Hepatitis B*
Humans ; Hepatitis B virus ; alpha-Fetoproteins ; Hepacivirus

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Global epidemiology of hepatitis C virus in dialysis patients: A systematic review and meta-analysis.
Autorzy:: Kenfack-Momo R; Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon.
Ngounoue MD; Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon.
Kenmoe S; Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
Takuissu GR; Centre for Food, Food Security and Nutrition Research, Institute of Medical Research and Medicinal Plants Studies, Yaounde, Cameroon.
Ebogo-Belobo JT; Medical Research Centre, Institute of Medical Research and Medicinal Plants Studies, Yaounde, Cameroon.
Kengne-Ndé C; Epidemiological Surveillance, Evaluation and Research Unit, National AIDS Control Committee, Douala, Cameroon.
Mbaga DS; Department of Microbiology, The University of Yaounde I, Yaounde, Cameroon.
Zeuko'o Menkem E; Department of Biomedical Sciences, University of Buea, Buea, Cameroon.
Lontuo Fogang R; Department of Animal Biology, University of Dschang, Dschang, Cameroon.
Tchatchouang S; Scientific Direction, Centre Pasteur du Cameroun, Yaoundé, Cameroon.
Ndzie Ondigui JL; Department of Microbiology, The University of Yaounde I, Yaounde, Cameroon.
Kame-Ngasse GI; Medical Research Centre, Institute of Medical Research and Medicinal Plants Studies, Yaounde, Cameroon.
Kenfack-Zanguim J; Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon.
Magoudjou-Pekam JN; Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon.
Bowo-Ngandji A; Department of Microbiology, The University of Yaounde I, Yaounde, Cameroon.
Mahamat M; Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon.; Hemodialysis Unit, Yaoundé General Hospital, Yaoundé, Cameroon.
Nkie Esemu S; Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
Ndip L; Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
Njouom R; Virology Department, Centre Pasteur of Cameroon, Yaoundé, Cameroon.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Feb 08; Vol. 19 (2), pp. e0284169. Date of Electronic Publication: 2024 Feb 08 (Print Publication: 2024).
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Hepatitis C*
Kidney Failure, Chronic*/epidemiology
Kidney Failure, Chronic*/therapy
Kidney Failure, Chronic*/etiology
Peritoneal Dialysis*/adverse effects
Humans ; Hepacivirus ; Renal Dialysis/adverse effects ; Prevalence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Sociodemographic characteristics associated with hepatitis C virus infection in Vietnamese Americans: A cross-sectional analysis of community screening data.
Autorzy:: Lee AW; Department of Public Health, California State University, Fullerton, Fullerton, CA, United States of America.
Jacobs W; Department of Kinesiology, California State University, Stanislaus, Turlock, CA, United States of America.
Tran M; Department of Public Health, California State University, Fullerton, Fullerton, CA, United States of America.
Nguyen B; Vietnamese American Cancer Foundation, Fountain Valley, CA, United States of America.
Hua DN; Vietnamese American Cancer Foundation, Fountain Valley, CA, United States of America.
Ho JN; Vietnamese American Cancer Foundation, Fountain Valley, CA, United States of America.
Van Nguyen T; Vietnamese American Cancer Foundation, Fountain Valley, CA, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 Sep 27; Vol. 17 (9), pp. e0275210. Date of Electronic Publication: 2022 Sep 27 (Print Publication: 2022).
Typ publikacji:: Journal Article
MeSH Terms:: Hepacivirus*
Hepatitis C*/diagnosis
Hepatitis C*/epidemiology
Aged ; Asian ; Cross-Sectional Studies ; Female ; Hepatitis C Antibodies ; Humans ; Male ; Prevalence ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019.
Autorzy:: Facente SN; Facente Consulting, Richmond, CA, United States of America.; Vitalant Research Institute, San Francisco, CA, United States of America.
Grinstein R; San Francisco Department of Public Health, San Francisco, CA, United States of America.
Bruhn R; Vitalant Research Institute, San Francisco, CA, United States of America.
Kaidarova Z; Vitalant Research Institute, San Francisco, CA, United States of America.
Wilson E; San Francisco Department of Public Health, San Francisco, CA, United States of America.
Hecht J; San Francisco AIDS Foundation, San Francisco, CA, United States of America.; Springboard HealthLab, Berkeley, CA, United States of America.
Burk K; Facente Consulting, Richmond, CA, United States of America.; San Francisco Department of Public Health, San Francisco, CA, United States of America.
Grebe E; Vitalant Research Institute, San Francisco, CA, United States of America.; University of California, San Francisco, San Francisco, CA, United States of America.; South African Centre for Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa.
Morris MD; University of California, San Francisco, San Francisco, CA, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 May 11; Vol. 17 (5), pp. e0267902. Date of Electronic Publication: 2022 May 11 (Print Publication: 2022).
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/epidemiology
Hepatitis C*/diagnosis
Hepatitis C*/epidemiology
Sexual and Gender Minorities*
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/epidemiology
Cross-Sectional Studies ; Female ; Hepacivirus ; Hepatitis C Antibodies ; Homosexuality, Male ; Humans ; Male ; Population Density ; Prevalence ; San Francisco/epidemiology ; Seroepidemiologic Studies

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: HIV, hepatitis B virus, and hepatitis C virus co-infection among HIV positives in antiretroviral treatment program in selected hospitals in Addis Ababa: A retrospective cross-sectional study.
Autorzy:: Seyoum E; Institute of Public Health, University of Gondar, Gondar, Ethiopia.; Epidemiology and Evaluation Department, Addis Continental Institute of Public Health, Addis Ababa, Ethiopia.
Demissie M; Public Health Department, Addis Continental Institute of Public Health, Addis Ababa, Ethiopia.
Worku A; Department of Preventive Medicine, School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Mulu A; Bacterial and Viral Diseases Research Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Abdissa A; Bacterial and Viral Diseases Research Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Berhane Y; Epidemiology and Evaluation Department, Addis Continental Institute of Public Health, Addis Ababa, Ethiopia.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 Apr 22; Vol. 17 (4), pp. e0267230. Date of Electronic Publication: 2022 Apr 22 (Print Publication: 2022).
Typ publikacji:: Journal Article
MeSH Terms:: Coinfection*
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Hepatitis B*/complications
Hepatitis B*/drug therapy
Hepatitis B*/epidemiology
Hepatitis C*/complications
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Adult ; Anti-Retroviral Agents/therapeutic use ; Cross-Sectional Studies ; Ethiopia/epidemiology ; Female ; Hepacivirus ; Hepatitis B Surface Antigens/therapeutic use ; Hepatitis B virus ; Hepatitis C Antibodies ; Hospitals ; Humans ; Male ; Prevalence ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Blood donations and donors' profile in Lithuania: Trends for coming back after the COVID-19 outbreak.
Autorzy:: Kalibatas V; Department of Health Management, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Kalibatienė L; Department of Anaesthesiogy, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Imashpayev D; Scientific and Production Center of Transfusiology, Astana, Kazakhstan.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Jan 25; Vol. 19 (1), pp. e0297580. Date of Electronic Publication: 2024 Jan 25 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*/epidemiology
Hepatitis C*/epidemiology
Transfusion Reaction*/epidemiology
Humans ; Adult ; Blood Donation ; Lithuania/epidemiology ; Blood Donors ; Disease Outbreaks

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Two risk factors for hypozincemia in diabetic β-thalassemia patients: Hepatitis C and deferasirox.
Autorzy:: Darvishi-Khezri H; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Karami H; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Naderisorki M; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Ghazaiean M; Gut and Liver Research Center, Non-communicable Disease Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Kosaryan M; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Mosanejad-Galchali A; MD. Islamic Azad University, Sari Branch, Mazandaran, Iran.
Aliasgharian A; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Karami H; Department of Pediatrics, Mazandaran University of Medical Sciences, Sari, Iran.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Jan 12; Vol. 19 (1), pp. e0284267. Date of Electronic Publication: 2024 Jan 12 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: beta-Thalassemia*/complications
beta-Thalassemia*/drug therapy
Iron Overload*/complications
Thalassemia*/epidemiology
Hepatitis C*/complications
Diabetes Mellitus*/drug therapy
Diabetes Mellitus*/chemically induced
Humans ; Female ; Male ; Deferasirox/therapeutic use ; Blood Glucose ; Risk Factors ; Zinc ; Iron Chelating Agents/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Distribution pattern, molecular transmission networks, and phylodynamic of hepatitis C virus in China.
Autorzy:: Ye J; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC), Dong Chen District, Beijing, China.
Sun Y; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC), Dong Chen District, Beijing, China.
Li J; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC), Dong Chen District, Beijing, China.
Lu X; Institute for HIV/AIDS and STD Prevention and Control, Hebei CDC, Shijiazhuang, Hebei, China.
Zheng M; Institute for HIV/AIDS and STD Prevention and Control, Tianjin CDC, Hedong District, Tianjin, China.
Liu L; Center for Infectious Diseases, Beijing YouAn Hospital, Capital Medical University, Feng Tai District, Beijing, China.
Yu F; Clinical and Research Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Chaoyang District, Beijing, China.
He S; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC), Dong Chen District, Beijing, China.
Xu C; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC), Dong Chen District, Beijing, China.
Ren X; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC), Dong Chen District, Beijing, China.
Wang J; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC), Dong Chen District, Beijing, China.
Chen J; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC), Dong Chen District, Beijing, China.
Ruan Y; Division of Virology and Immunology, State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Center for AIDS/STD Prevention and Control (NCAIDS), China CDC, Changping District, Beijing, China.
Feng Y; Division of Virology and Immunology, State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Center for AIDS/STD Prevention and Control (NCAIDS), China CDC, Changping District, Beijing, China.
Shao Y; Division of Virology and Immunology, State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Center for AIDS/STD Prevention and Control (NCAIDS), China CDC, Changping District, Beijing, China.
Xing H; Division of Virology and Immunology, State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Center for AIDS/STD Prevention and Control (NCAIDS), China CDC, Changping District, Beijing, China.
Lu H; Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC), Dong Chen District, Beijing, China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Dec 21; Vol. 18 (12), pp. e0296053. Date of Electronic Publication: 2023 Dec 21 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*
Sexual and Gender Minorities*
Hepatitis C*
Male ; Humans ; Hepacivirus/genetics ; Homosexuality, Male ; Phylogeny ; China/epidemiology ; Genotype

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Racial differences in testing for infectious diseases: An analysis of jail intake data.
Autorzy:: Wurcel AG; Department of Medicine Tufts Medical Center, Division of Geographic Medicine and Infectious Diseases, Boston, MA, United States of America.; Tufts University School of Medicine, Boston, MA, United States of America.
Guardado R; Department of Medicine Tufts Medical Center, Division of Geographic Medicine and Infectious Diseases, Boston, MA, United States of America.
Grussing ED; Department of Medicine Tufts Medical Center, Division of Geographic Medicine and Infectious Diseases, Boston, MA, United States of America.; Tufts University School of Medicine, Boston, MA, United States of America.
Koutoujian PJ; Middlesex Sheriff's Office, Medford, MA, United States of America.
Siddiqi K; Middlesex Sheriff's Office, Medford, MA, United States of America.
Senst T; Middlesex Sheriff's Office, Medford, MA, United States of America.
Assoumou SA; Boston University School of Medicine, Boston, MA, United States of America.; Boston Medical Center, Boston, MA, United States of America.
Freund KM; Tufts University School of Medicine, Boston, MA, United States of America.; Department of Medicine, Tufts Medical Center, Boston, MA, United States of America.
Beckwith CG; The Miriam Hospital/Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Dec 20; Vol. 18 (12), pp. e0288254. Date of Electronic Publication: 2023 Dec 20 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Hepatitis C*/diagnosis
HIV Infections*/diagnosis
Humans ; Jails ; Retrospective Studies ; Race Factors ; Hepacivirus

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Metabolic, renal, and hematological changes in chronic hepatitis C patients achieving rapid virologic response after 12 weeks of direct-acting antiviral treatment: A prospective cohort study.
Autorzy:: Thi Thu PN; Haiphong International Hospital, Haiphong, Vietnam.; Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.
Hoang Van D; Haiphong International Hospital, Haiphong, Vietnam.
Ngo Thi Quynh M; Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.
Tran Thi N; Haiphong International Hospital, Haiphong, Vietnam.; Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.
Pham Minh K; Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.
Pham Van L; Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Sep 01; Vol. 18 (9), pp. e0290235. Date of Electronic Publication: 2023 Sep 01 (Print Publication: 2023).
Typ publikacji:: Observational Study; Journal Article
MeSH Terms:: Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/drug therapy
Hepatitis C*
Humans ; Female ; Antiviral Agents/therapeutic use ; Prospective Studies ; Glycated Hemoglobin ; Hepacivirus/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: TROLLOPE: A novel sequence-based stacked approach for the accelerated discovery of linear T-cell epitopes of hepatitis C virus.
Autorzy:: Charoenkwan P; Modern Management and Information Technology, College of Arts, Media and Technology, Chiang Mai University, Chiang Mai, Thailand.
Waramit S; Department of Zoology, Faculty of Science, Kasetsart University, Bangkok, Thailand.
Chumnanpuen P; Department of Zoology, Faculty of Science, Kasetsart University, Bangkok, Thailand.; Omics Center for Agriculture, Bioresources, Food, and Health, Kasetsart University (OmiKU), Bangkok, Thailand.
Schaduangrat N; Center for Research Innovation and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand.
Shoombuatong W; Center for Research Innovation and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Aug 25; Vol. 18 (8), pp. e0290538. Date of Electronic Publication: 2023 Aug 25 (Print Publication: 2023).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hepatitis C*
Hepatitis C, Chronic*
Humans ; Hepacivirus/genetics ; Epitopes, T-Lymphocyte ; Algorithms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: The impact of expanded access to direct acting antivirals for Hepatitis C virus on patient outcomes in Canada.
Autorzy:: Chu C; Institute for Health System Solutions and Virtual Care, Women's College Hospital, Toronto, ON, Canada.
Gomes T; Unity Health Toronto, Toronto, ON, Canada.; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.; Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.
Antoniou T; Unity Health Toronto, Toronto, ON, Canada.; Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.; Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada.
Wong WWL; Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.; School of Pharmacy, University of Waterloo, Kitchener, ON, Canada.
Janjua N; BC Centre for Disease Control, Vancouver, BC, Canada.; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Guertin JR; Département de médecine sociale et préventive, Faculté de médecine, Université Laval, Quebec City, QC, Canada.; Centre de recherche du CHU de Québec-Université Laval, Quebec City, QC, Canada.; Centre de Recherche en Organogénèse expérimentale de l'Université Laval/LOEX, Quebec City, QC, Canada.
Schwartz KL; Public Health Ontario, Toronto, ON, Canada.; St. Joseph's Health Centre, Unity Health Toronto, Toronto, ON, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Feld J; Toronto Centre for Liver Disease, University Health Network, Toronto, ON, Canada.
Kwong J; Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.; Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada.; Public Health Ontario, Toronto, ON, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Tadrous M; Institute for Health System Solutions and Virtual Care, Women's College Hospital, Toronto, ON, Canada.; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.; Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Aug 08; Vol. 18 (8), pp. e0284914. Date of Electronic Publication: 2023 Aug 08 (Print Publication: 2023).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/epidemiology
Carcinoma, Hepatocellular*/complications
Liver Neoplasms*/drug therapy
Liver Neoplasms*/epidemiology
Liver Neoplasms*/complications
Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/epidemiology
Hepatitis C, Chronic*/complications
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Hepatitis C*/complications
Male ; Humans ; Hepacivirus ; Antiviral Agents/therapeutic use ; Canada/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Maternal and neonatal outcomes in patients with hepatitis C and intrahepatic cholestasis of pregnancy: The sum of the parts.
Autorzy:: Goins EC; Duke University School of Medicine, Durham, North Carolina, United States of America.
Wein LE; Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.
Watkins VY; Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.
Campbell AIK; Duke University School of Medicine, Durham, North Carolina, United States of America.
Heine RP; Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America.
Hughes BL; Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.
Dotters-Katz SK; Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.
Federspiel JJ; Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.; Department of Gynecology and Obstetrics, The Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Oct 18; Vol. 18 (10), pp. e0293030. Date of Electronic Publication: 2023 Oct 18 (Print Publication: 2023).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Diabetes, Gestational*
Premature Birth*/etiology
Pregnancy Complications*/epidemiology
Cholestasis, Intrahepatic*/complications
Cholestasis, Intrahepatic*/epidemiology
Hepatitis C*/complications
Hepatitis C*/epidemiology
Respiratory Distress Syndrome*/complications
Sepsis*/complications
Humans ; Pregnancy ; Infant, Newborn ; Female ; Cesarean Section/adverse effects ; Retrospective Studies ; Hepacivirus ; Pregnancy Outcome
SCR Disease Name:: Intrahepatic Cholestasis of Pregnancy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Maternal hepatitis C virus infection and three adverse maternal outcomes in the United States.
Autorzy:: Hood RB; Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, United States of America.
Miller WC; Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, United States of America.
Shoben A; Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH, United States of America.
Harris RE; Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, United States of America.
Norris AH; Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Oct 18; Vol. 18 (10), pp. e0291994. Date of Electronic Publication: 2023 Oct 18 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Diabetes, Gestational*/epidemiology
Pregnancy Complications*
Hypertension, Pregnancy-Induced*
Eclampsia*/epidemiology
Hepatitis C*/complications
Hepatitis C*/epidemiology
Pregnancy ; Female ; Humans ; United States/epidemiology ; Pregnancy Outcome ; Hepacivirus ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: A novel formula used for predicting hepatocellular carcinoma after the achievement of sustained virologic response by direct-acting antivirals in patients with chronic hepatitis C.
Autorzy:: Yoshida Y; Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan.
Atsukawa M; Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan.; Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
Kondo C; Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
Kitamura M; Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
Shioda-Koyano K; Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
Kawano T; Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
Ono H; Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
Hayama K; Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan.
Okubo T; Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan.
Arai T; Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
Itokawa N; Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
Iwakiri K; Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Sep 21; Vol. 18 (9), pp. e0292019. Date of Electronic Publication: 2023 Sep 21 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/epidemiology
Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/drug therapy
Liver Neoplasms*/epidemiology
Humans ; Female ; Male ; Aged ; Antiviral Agents/therapeutic use ; Sustained Virologic Response ; Liver Cirrhosis/complications ; Liver Cirrhosis/drug therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Hepatitis C"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Język